Wright Hip Replacement MDL Officially Ends

Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

gavel and scales of justice

The multidistrict litigation (MDL) overseeing Wright Medical hip replacement lawsuits has officially ended. The last cases in the court were settled in October 2017. At that time, the judge overseeing the MDL asked a federal panel to stop transferring cases to the court.

After overseeing Wright hip litigation for six years, U.S. District Judge William Duffey issued an order closing the MDL on June 22, 2018.

MDLs are special courts for lawsuits that have the same defendant and similar facts. More than 600 lawsuits were transferred to the Wright hip MDL in the Northern District of Georgia.

Cases in the MDL involved Wright’s Conserve and Profemur hip implants. Plaintiffs injured by the devices sought compensation from Wright. They claimed the company’s metal-on-metal implants caused metallosis and other injuries.

Injured by a Wright hip replacement? Get a Free Case Review

The plaintiffs and defendant began settlement talks in June 2014, and the parties agreed to settle 1,292 claims across the country for an estimated $240 million in November 2016.

The parties agreed to two additional settlements totaling an estimated $90 million in October 2017. These settlements resolved the remaining cases in the MDL.

Wright sold its hip and knee replacement business in 2013. But the company is still liable for individuals who were harmed by its devices. The closing of the MDL does not mean it’s too late to file a lawsuit against the company if you were injured by a Wright hip implant.

About 28,000 hip replacement lawsuits have been filed against companies who manufactured and sold metal-on-metal hip implants. Several companies, including Wright, have settled the majority of the lawsuits against them. But more than 10,000 cases are still pending in MDLs across the country.

  •  
  •  
  •  

Did you find Drugwatch helpful?

6 Cited Research Articles

  1. Bellon, T. (2018, June 25). Federal judge closes Wright Medical hip implant MDL after settlement. Retrieved from https://www.reuters.com/article/products-wright-medical/federal-judge-closes-wright-medical-hip-implant-mdl-after-settlement-idUSL1N1TR20C
  2. U.S. District Court for the Northern District of Georgia. (2018, June 22). Order In Re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation. Retrieved from https://www.pacer.gov.
  3. U.S. District Court for the Northern District of Georgia. (2017, October 18). Suggestion Concerning Future Transfers In Re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation. Retrieved from http://www.gand.uscourts.gov/sites/default/files/wsd2329_doc2023.pdf
  4. U.S. District Court for the North District of Georgia. (2017, October 18). Order In Re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation. Retrieved from http://www.gand.uscourts.gov/sites/default/files/wsd2329_doc2022.pdf
  5. U.S. Judicial Panel on Multidistrict Litigation. (2018, June 15). MDL Statistics Report - Distribution of Pending MDL Dockets by District. Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-15-2018.pdf
  6. U.S. Securities and Exchange Commission. (2017, October 3). Form 8-K, Wright Medical Group N.V. Retrieved from: http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12311277&RcvdDate=10/4/2017&CoName=WRIGHT%20MEDICAL%20GROUP%20N.V.&FormType=8-K&View=orig
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(855) 396-3709

To contact Drugwatch Managing Editor Kevin Connolly, call (855) 839-9780.